MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-25-2026
Sundial Growers Operating Cash Flow 2011-2026 | SNDL
Annual Operating Cash Flow Sundial Growers
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | -155 M | -57.5 M | -113 M | -25.8 M | - | - | - | - | - | - | - |
All numbers in CAD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -25.8 M | -155 M | -87.9 M |
Operating Cash Flow of other stocks in the Drug manufacturers industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
435 M | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-5.46 M | - | - | $ 36.6 M |  USA |
 |
Cumberland Pharmaceuticals
CPIX
|
4.93 M | $ 5.7 | -0.35 % | $ 84.7 M | USA |
 |
HEXO Corp.
HEXO
|
-117 M | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-435 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
-11.4 M | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
-19.1 M | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-25.9 M | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-99.2 M | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
-9.58 M | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
-14.3 M | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
25.9 M | $ 2.84 | 1.61 % | $ 1.09 B | Canada |
 |
Athenex
ATNX
|
-131 M | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
43.9 M | $ 35.25 | 5.35 % | $ 1.3 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-46.9 M | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
268 M | - | - | $ 11.5 B | USA |
 |
Organogenesis Holdings
ORGO
|
-10.3 M | $ 2.53 | 2.02 % | $ 321 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
50.7 M | - | -39.89 % | $ 27.7 M | USA |
 |
Canopy Growth Corporation
CGC
|
-166 M | $ 1.04 | 2.09 % | $ 112 M | Canada |
 |
Pacira BioSciences
PCRX
|
189 M | $ 23.58 | 1.59 % | $ 1.09 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-88 K | $ 1.11 | - | $ 1.38 M | USA |
 |
Solid Biosciences
SLDB
|
-156 M | $ 6.79 | 3.36 % | $ 594 M | USA |
 |
Aurora Cannabis
ACB
|
16 M | $ 3.4 | 0.44 % | $ 186 M | Canada |
 |
Jupiter Wellness
JUPW
|
-6.4 M | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
-7.12 M | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
3.87 M | $ 1.09 | 0.93 % | $ 104 M | Canada |
 |
Tilray
TLRY
|
7.91 M | $ 5.19 | 0.43 % | $ 3.21 B | Canada |
 |
Evolus
EOLS
|
-42.3 M | $ 6.73 | 0.37 % | $ 434 M | USA |
 |
Emergent BioSolutions
EBS
|
171 M | $ 8.17 | 2.96 % | $ 437 M | USA |
 |
Veru
VERU
|
-30 M | $ 3.17 | 2.23 % | $ 46.4 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-77.2 M | - | - | $ 193 M | Canada |
 |
cbdMD
YCBD
|
-1.45 M | $ 0.72 | -0.1 % | $ 2.9 M | USA |
 |
Assertio Holdings
ASRT
|
-28.2 M | $ 23.48 | 0.06 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
-8.34 M | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
-22.4 M | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
1.4 B | $ 5.2 | 0.48 % | $ 1.93 B | Canada |
 |
PetIQ
PETQ
|
61.9 M | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
-45.8 M | $ 6.6 | 5.26 % | $ 261 M | USA |
 |
Recro Pharma
REPH
|
-1 M | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
-44.7 M | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
-5.28 M | $ 4.3 | -1.37 % | $ 215 M | USA |
 |
PLx Pharma
PLXP
|
-32.1 M | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
2.32 B | $ 16.16 | -0.28 % | $ 18.8 B | USA |
 |
Zomedica Corp.
ZOM
|
-17.6 M | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-23 M | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
-659 K | $ 0.67 | -2.01 % | $ 24.1 M | USA |
 |
Tricida
TCDA
|
-140 M | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
148 K | $ 0.72 | -1.0 % | $ 3.09 M |  China |
 |
TherapeuticsMD
TXMD
|
-159 M | $ 1.96 | 4.26 % | $ 22.7 M | USA |